VIEWPOINT MOLECULAR TARGETING

"Next Generation Personalized Cancer Therapy"
Chief Science Officer: Michael Schultz

University:
University of Iowa
Startup Officer: Paul Dymerski

Technology Area:
  • Pharmaceuticals and Medical

Website: http://www.viewpointmt.com
Viewpoint Molecular Targeting, LLC is a pharmaceutical company that develops targeted radiation therapies and diagnostics for cancer, with a current focus on metastatic melanoma.
Articles to be posted soon.

Please publish modules in offcanvas position.